Pfizer Escapes Shareholder Suit Over Wyeth Alzheimer's Drug
A New Jersey federal judge on Monday threw out an amended shareholder class action contending Pfizer Inc. deceived investors about the efficacy of Wyeth Inc.'s Alzheimer's drug bapineuzumab, finding the plaintiffs...To view the full article, register now.
Already a subscriber? Click here to view full article